Oncology Based Molecular Diagnostic Market
Table of Contents
Global Oncology Based Molecular Diagnostic Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Oncology Based Molecular Diagnostic Market by Value
2.2.1 Global Oncology Based Molecular Diagnostic Revenue by Type
2.2.2 Global Oncology Based Molecular Diagnostic Market by Value (%)
2.3 Global Oncology Based Molecular Diagnostic Market by Production
2.3.1 Global Oncology Based Molecular Diagnostic Production by Type
2.3.2 Global Oncology Based Molecular Diagnostic Market by Production (%)
3. The Major Driver of Oncology Based Molecular Diagnostic Industry
3.1 Historical & Forecast Global Oncology Based Molecular Diagnostic Demand
3.2 Largest Application for Oncology Based Molecular Diagnostic (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Oncology Based Molecular Diagnostic Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Oncology Based Molecular Diagnostic Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Oncology Based Molecular Diagnostic Average Price Trend
12.1 Market Price for Each Type of Oncology Based Molecular Diagnostic in US (2018-2022)
12.2 Market Price for Each Type of Oncology Based Molecular Diagnostic in Europe (2018-2022)
12.3 Market Price for Each Type of Oncology Based Molecular Diagnostic in China (2018-2022)
12.4 Market Price for Each Type of Oncology Based Molecular Diagnostic in Japan (2018-2022)
12.5 Market Price for Each Type of Oncology Based Molecular Diagnostic in India (2018-2022)
12.6 Market Price for Each Type of Oncology Based Molecular Diagnostic in Korea (2018-2022)
12.7 Market Price for Each Type of Oncology Based Molecular Diagnostic in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Oncology Based Molecular Diagnostic Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Oncology Based Molecular Diagnostic
14. Oncology Based Molecular Diagnostic Competitive Landscape
14.1 Abbott
14.1.1 Abbott Company Profiles
14.1.2 Abbott Product Introduction
14.1.3 Abbott Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Bayer Healthcare
14.2.1 Bayer Healthcare Company Profiles
14.2.2 Bayer Healthcare Product Introduction
14.2.3 Bayer Healthcare Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Beckton Dickinson
14.3.1 Beckton Dickinson Company Profiles
14.3.2 Beckton Dickinson Product Introduction
14.3.3 Beckton Dickinson Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Cepheid
14.4.1 Cepheid Company Profiles
14.4.2 Cepheid Product Introduction
14.4.3 Cepheid Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Dako
14.5.1 Dako Company Profiles
14.5.2 Dako Product Introduction
14.5.3 Dako Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Hologic
14.6.1 Hologic Company Profiles
14.6.2 Hologic Product Introduction
14.6.3 Hologic Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Qiagen
14.7.1 Qiagen Company Profiles
14.7.2 Qiagen Product Introduction
14.7.3 Qiagen Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Roche
14.8.1 Roche Company Profiles
14.8.2 Roche Product Introduction
14.8.3 Roche Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Siemens Healthineers
14.9.1 Siemens Healthineers Company Profiles
14.9.2 Siemens Healthineers Product Introduction
14.9.3 Siemens Healthineers Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Sysmex
14.10.1 Sysmex Company Profiles
14.10.2 Sysmex Product Introduction
14.10.3 Sysmex Oncology Based Molecular Diagnostic Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Demand by Application of Oncology Based Molecular Diagnostic Industry (Volume)
Figure 2. Oncology Based Molecular Diagnostic Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Oncology Based Molecular Diagnostic Revenue in 2022
Figure 5. US Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Oncology Based Molecular Diagnostic Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Oncology Based Molecular Diagnostic Revenue, by Type (Million USD) (2018-2028)
Table 4. Oncology Based Molecular Diagnostic Production, by Type (K Unit) (2018-2028)
Table 5. Oncology Based Molecular Diagnostic Demand (K Unit) by Application (2018-2028)
Table 6. Oncology Based Molecular Diagnostic Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Oncology Based Molecular Diagnostic Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Oncology Based Molecular Diagnostic Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Oncology Based Molecular Diagnostic in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Profiles
Table 61. Abbott Oncology Based Molecular Diagnostic Product Introduction
Table 62. Abbott Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Strategic initiatives
Table 64. Bayer Healthcare Profiles
Table 65. Bayer Healthcare Oncology Based Molecular Diagnostic Product Introduction
Table 66. Bayer Healthcare Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Bayer Healthcare Strategic initiatives
Table 68. Beckton Dickinson Profiles
Table 69. Beckton Dickinson Oncology Based Molecular Diagnostic Product Introduction
Table 70. Beckton Dickinson Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Beckton Dickinson Strategic initiatives
Table 72. Cepheid Profiles
Table 73. Cepheid Oncology Based Molecular Diagnostic Product Introduction
Table 74. Cepheid Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Cepheid Strategic initiatives
Table 76. Dako Profiles
Table 77. Dako Oncology Based Molecular Diagnostic Product Introduction
Table 78. Dako Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. Dako Strategic initiatives
Table 80. Hologic Profiles
Table 81. Hologic Oncology Based Molecular Diagnostic Product Introduction
Table 82. Hologic Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Hologic Strategic initiatives
Table 84. Qiagen Profiles
Table 85. Qiagen Oncology Based Molecular Diagnostic Product Introduction
Table 86. Qiagen Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Qiagen Strategic initiatives
Table 88. Roche Profiles
Table 89. Roche Oncology Based Molecular Diagnostic Product Introduction
Table 90. Roche Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Roche Strategic initiatives
Table 92. Siemens Healthineers Profiles
Table 93. Siemens Healthineers Oncology Based Molecular Diagnostic Product Introduction
Table 94. Siemens Healthineers Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Siemens Healthineers Strategic initiatives
Table 97. Sysmex Profiles
Table 98. Sysmex Oncology Based Molecular Diagnostic Product Introduction
Table 99. Sysmex Oncology Based Molecular Diagnostic Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Sysmex Strategic initiatives
Industry Market Size
